FOXP3 and colorectal cancer: Treg cells are suggested to inhibit protumorigenic effects by suppressing proinflammatory and tumor-promoting abilities of Th17 cells [37], providing a possible explanation for the favorable prognostic role of FOXP3+ Treg cells in colorectal cancer [38].